Paul D. Thompson MDChief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine –Emeritus, University of Connecticut, Storrs, Connecticut; Staff Cardiologist, Massachusetts General Hospital, Boston, Massachusetts
Paul D. Thompson, MD, graduated from Tufts College and from Tufts Medical School. He served as a medical intern and resident at Tufts New England Medical Center and completed his training in cardiology at Stanford Medical Center.
Dr. Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine – Emeritus at the University of Connecticut. He is a Staff Cardiologist at the Massachusetts General Hospital, Boston, Massachusetts. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992. He has authored over 500 scientific articles on topics which include: the treatment of cardiovascular risk factors, the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function, and genetic factors affecting the exercise response. His past NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of Coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia. Dr. Thompson is the Co-Editor of the book Exercise and Sports Cardiology and of the book Statin Associated Muscle Symptoms. He is a Past President of the American College of Sports Medicine.
Paul D. Thompson, MD, has received research support from Esperion and Norvartis; owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, and Sarepta; and has provided legal consultation on exercise-related cardiac events and statin myopathy.
Recent Contributions to PracticeUpdate:
- Changes in Cardiorespiratory Fitness and Survival in Patients With or Without CVD
- ACC 2023: Recommendations From Dr. Paul Thompson
- Effect of Low-Volume High-Intensity Interval Training in Cardiac Rehabilitation
- Decreasing the Effects of Aldosterone in Resistant Hypertension
- Exercise Volume vs Intensity and the Progression of Coronary Atherosclerosis in Middle-Aged and Older Athletes
- Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality
- 2022 Top Story in Cardiology: Statins Can Cause Muscle Symptoms
- Effect of Vitamin D on Statin-Associated Muscle Symptoms Among New Statin Users
- Associations Between Timing of Physical Activity and CVD Risk
- Associations Between Vigorous Physical Activity and Incident CVD and Cancer